[pubmed] COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature

[RSS-Bot]

Case Rep Infect Dis. 2020 Aug 17;2020:8845844. doi: 10.1155/2020/8845844. eCollection 2020.

ABSTRACT

Currently, there are scarce data on how COVID-19 affects people with myasthenia gravis. Theoretically, there is a higher risk of experiencing severe manifestations of COVID-19 due to the common use of immunosuppressive drugs and potential respiratory failure in relation to respiratory muscle weakness. This is one of the early cases of COVID-19 reported in association with myasthenia gravis. Here, we highlight the prognosis, discuss the pathophysiological mechanisms, and prompt the consideration of convalescent plasma therapy in myasthenia gravis patients with concomitant COVID-19.

PMID:32850160 | PMC:PMC7436352 | DOI:10.1155/2020/8845844


Source: https://pubmed.ncbi.nlm.nih.gov/3285016 ... 7&v=2.11.5